OverviewTyber Edge is changing the way Life Science companies innovate, prioritize and realize the value of strategic investments in products, people, and platforms.The Tyber Edge investment methodology shifts internal investment decisions:- to data driven, from human biased- to dynamically optimized, from annual bureaucracy- to visible results, from hidden mediocrityApplying the disciplines of financial portfolio managers, the Tyber Edge framework helps BioPharma executives from discovery through sales, deliver tangible results from constrained financial resources.